Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NKAIN3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
GOT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FBL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
COL8A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TNP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TCEB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TAMM41 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NUS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
OXA1L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00454 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
SYCE1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HSPB2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ASNS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ITGA8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C20orf96 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPL17-C18orf32 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCBP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HFE - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on